Edward Wakeland

Professor

University of Texas Southwestern Medical Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Edward Wakeland is a Professor at The University of Texas Southwestern Medical Center, located in the United States. His research areas include immune-related adverse events, systemic immune parameters in cancer patients, and the genetic underpinnings of autoimmune diseases. Recent publications highlight his work on the predictors of immune responses in various therapeutic contexts, including immune checkpoint inhibitors and interleukin-2 therapy.

Articles (10)

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

UNITED STATES

View details

Andrew Y. Koh

University of Texas Southwestern Medical Center

UNITED STATES

View details

Ran Song

University of Texas Southwestern Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Edward Wakeland

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

T-cell tolerant fraction as a predictor of immune-related adverse events.

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors

Association between Antibiotic Exposure and Systemic Immune Parameters in Cancer Patients Receiving Checkpoint Inhibitor Therapy

Loss-of-function variants in <i>SAT1</i> cause X-linked childhood-onset systemic lupus erythematosus.

IRF1 governs the differential interferon-stimulated gene responses in human monocytes and macrophages by regulating chromatin accessibility.

Serum IgG Profiling of Toddlers Reveals a Subgroup with Elevated Seropositive Antibodies to Viruses Correlating with Increased Vaccine and Autoantigen Responses

A conserved long noncoding RNA, GAPLINC, modulates the immune response during endotoxic shock

Association between body mass index, dosing strategy, and efficacy of immune checkpoint inhibitors.

Humoral and cellular correlates of a novel immune-related adverse event and its treatment.

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma.

Collaborators (8)

David Gerber

Nicolai van Oers

Betty Tsao

Shaheen Khan

Leah Kottyan

Yuanyuan Zhang

Andrew Y. Koh

Ran Song

Make your next move.